CareRx Corporation

CRRX

CA14173C1059

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 20:00:05 21/06/2024 BST			5-day change	1st Jan Change
2.3 ^CAD	-0.43%		0.00%	+42.86%

05-29	CareRx Brief: Dalton will be succeeded by Jeff Watson, a current independent director of the Board	MT
05-29	CareRx Brief: Kevin Dalton, Chairman of the Board for the last six years, will be retiring as Chairman effectively immediately	MT

Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.

March 07, 2024 at 12:03 pm

From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 29,392 shares, representing 0.05% for CAD 0.06 million under the buyback announced on August 28, 2023.

Latest news about CareRx Corporation

CareRx Brief: Dalton will be succeeded by Jeff Watson, a current independent director of the Board	05-29	MT
CareRx Brief: Kevin Dalton, Chairman of the Board for the last six years, will be retiring as Chairman effectively immediately	05-29	MT
CareRx Corporation Announces Board Changes	05-29	CI
CareRx Brief: Company Undertaking a search for a new CFO; Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim CFO	05-13	MT
CareRx Brief: Says Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity	05-13	MT
CareRx Corporation Announces CFO Transition	05-13	CI
Transcript : CareRx Corporation, Q1 2024 Earnings Call, May 10, 2024	05-10
CareRx Q1 Net Loss Narrows, Revenue Dips	05-10	MT
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.	05-10	CI
CareRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
CareRx Brief: Q1 Revenue $89.7 million; Net loss for the quarter was $0.5 million	05-10	MT
North American Morning Briefing : Stocks Set to -2-	05-10	DJ
CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes	04-01	MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes	04-01	MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan	03-27	MT
CareRx Narrows Q4 Loss, Revenue Falls	03-07	MT
Transcript : CareRx Corporation, Q4 2023 Earnings Call, Mar 07, 2024	03-07
CareRx Brief: Revenue for Q4 $91.1 million; Net loss for the quarter was $3.7 million	03-07	MT
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.	03-07	CI
CareRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-07	CI
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023	03-07	CI
North American Morning Briefing : Powell Still in -2-	03-07	DJ
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	03-07	DJ
CareRx Corporation Announces Closing of $70 Million Debt Refinancing	12-21	CI
CareRx Completes C$70-Million Debt Refinancing	12-21	MT

Chart CareRx Corporation

Duration

Period

More charts

Company Profile

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.

Sector

Drug Retailers

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for CareRx Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.3 CAD

Average target price

3.875 CAD

Spread / Average Target

+68.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
CARERX CORPORATION	+42.86%	101M
WALGREENS BOOTS ALLIANCE, INC.	-38.84%	13.78B
JD HEALTH INTERNATIONAL INC.	-40.79%	9.56B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-18.63%	7.21B
MATSUKIYOCOCOKARA & CO.	-9.73%	5.68B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+73.68%	4.6B
NAHDI MEDICAL COMPANY	-4.38%	4.58B
YIFENG PHARMACY CHAIN CO., LTD.	-18.93%	4.52B
CLICKS GROUP LIMITED	+4.63%	4.52B
WELCIA HOLDINGS CO., LTD.	-17.13%	2.58B

Other Drug Retailers

CareRx Corporation

Equities

CRRX

CA14173C1059

Drug Retailers

Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.

EPS Revisions